Immunohistochemical investigation of transferrin receptor 2 (TFR2) immunoreactivity in patients with cutaneous lichen planus

dc.contributor.authorCelik, Mehmet Semih
dc.contributor.authorAsir, Firat
dc.contributor.authorAktas, Hamza
dc.contributor.authorCetin, Alpay
dc.contributor.authorCelik, Candan
dc.contributor.authorCepik, Nagehan
dc.contributor.authorYildirim, Esma
dc.date.accessioned2026-08-12T17:28:23Z
dc.date.issued2026
dc.departmentFırat Üniversitesi
dc.description.abstractBackround and aim Lichen planus (LP) is a chronic inflammatory dermatosis with an unclear pathogenesis. Recent studies suggest that iron metabolism, oxidative stress, and ferroptosis mechanisms may play a role in the development of LP. Transferrin Receptor 2 (TFR2), an important receptor in iron homeostasis, may contribute to these processes. Methods TFR2 immunoreactivity was evaluated using immunohistochemical methods on skin biopsies obtained from patients diagnosed with cutaneous LP (n = 45) and healthy controls (n = 30). Staining intensity was measured with QuPath image analysis software using 3,3 '-diaminobenzidine (DAB). In addition, histopathological findings and staining localization were examined. Results In healthy skin samples, TFR2 expression was limited, showing only weak staining in the basal epidermis and mild cytoplasmic positivity around the dermal vasculature (mean DAB intensity: 22.0% +/- 5.5). In contrast, LP lesions exhibited pronounced epidermal irregularities, hyperkeratosis, inflammatory infiltration, and significantly increased TFR2 expression (mean DAB intensity: 57.0% +/- 5.9; p < 0.05). Notably, strong cytoplasmic staining was observed in the epidermal basal layer and dermal inflammatory cells. Conclusion This study demonstrated a significantly increased expression of TFR2 in LP lesions compared to healthy skin. The findings suggest that TFR2 may contribute to the pathogenesis of LP through the ferroptosis mechanism mediated by oxidative stress. However, further advanced studies evaluating specific markers related to ferroptosis are needed to better clarify this relationship.
dc.identifier.doi10.1007/s11845-025-04210-0
dc.identifier.endpage308
dc.identifier.issn0021-1265
dc.identifier.issn1863-4362
dc.identifier.issue1
dc.identifier.orcid0000-0002-3378-0619
dc.identifier.orcid0000-0003-3610-500X
dc.identifier.orcid0009-0000-6083-1840
dc.identifier.orcid0009-0008-6759-388X
dc.identifier.pmid41430519
dc.identifier.scopus2-s2.0-105025695238
dc.identifier.scopusqualityQ1
dc.identifier.startpage303
dc.identifier.urihttps://doi.org/10.1007/s11845-025-04210-0
dc.identifier.urihttps://hdl.handle.net/11508/55263
dc.identifier.volume195
dc.identifier.wosWOS:001644843700001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer London Ltd
dc.relation.ispartofIrish Journal of Medical Science
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectFerroptosis
dc.subjectLichen planus
dc.subjectOxidative stress
dc.subjectTFR2
dc.titleImmunohistochemical investigation of transferrin receptor 2 (TFR2) immunoreactivity in patients with cutaneous lichen planus
dc.typeArticle

Dosyalar